Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.


Working groups update

Launch of G-I-N North America, update from the Implementation Working Group and the Evidence Tables Working Group .

G-I-N North Americam community

The exploratory session for G-I-N North America attracted 100 attendees in Chicago at the 7th Annual G-I-N Conference in August 2010. Participants expressed several concerns that would benefit from a regional community, including (a) heterogeneous guideline processes with minimal national oversight, (b) guideline development by diverse societies, groups, and organizations, (c) new standards from the Institute of Medicine that would have broad implications for guideline processes, including possible accreditation, (d) challenges in getting funding and support, and (e) a regional desire to communicate and share best practices.

The G-I-N Board agreed in October, 2010 to pilot test regional chapters. A preliminary steering group was formed with North American and G-I-N representatives, resulting in Terms for Reference that led to a more permanent steering committee in April 2011. Interest in G-I-N North America was reaffirmed in May, 2011 when the community was officially launched during an invited presentation at The Institute of Medicine’s workshop on implementing standards for trustworthy clinical practice guidelines. Workshop participants included Philip van der Wees (Chair of G-I-N), Amir Qaseem (G-I-N Board member), Rick Shiffman (G-I-N member), and Richard Rosenfeld (G-I-N member and Chair of the North American Community).

G-I-N North America’s preliminary aims and objectives are to:

  • Provide a network for North American guideline users, developers, and other stakeholders to form partnerships and discuss regional guideline issues
  • Improve the efficiency and effectiveness of evidence-based guideline development, adaptation, dissemination, and implementation
  • Enhance and promote relationships between G-I-N and the North American guideline community
  • Organize and promote regional events that are non-competitive with the annual G-I-N conference
  • Coordinate guideline activities with other health quality initiatives

In the coming year the community seeks to expand membership, refine the aims and objectives, develop an advisory committee, and plan initial projects and conferences. Efforts will also focus on defining opportunities and obstacles for implementing the Institute of Medicine Standards for Trustworthy Clinical Practice Guidelines (

Members of the Steering Group:

  • Richard M. Rosenfeld, MD, MPH, Chair (United States)
  • Rebecca Burkholder, JD (United States)
  • Pedro G. Castrellón, MD, MsC, DsC (Mexico)
  • Dave Davis, MD, CCFP, FCFP (United States)
  • Kay Dickersin, PhD (United States)
  • Marguerite Koster, MA, MFT (United States)
  • Sandra Zelman Lewis, PhD (United States)
  • Sam E.D. Shortt, MD, PhD, FCFP (Canada)
  • Holger Schünemann, MD, MSc, PhD (Canada)
  • Richard N. Shiffman, MD, MCIS (United States)
  • Philip van der Wees, PhD, PT (The Netherlands)
  • Peter Wyer, MD (United States)


For more information, please visit G-I-N North America at the G-I-N website ( and plan to attend our inaugural community meeting in Seoul, Korea.

Implementation working group (IWG)

Below are some information about the work of the group this year and calls for expressions of interest from people with time (and passion!) to devote to being active members of the group and undertaking some of the work necessary to move existing projects forward and start new projects of relevance to the IWG.

Work of the Group

Members of the G-I-N community have been undertaking specific projects relating to implementation including:

Taxonomy – a project to develop a G-I-N-endorsed taxonomy of implementation terms.

Member Survey – we plan to include questions on use of implementation methods by member organizations within the G-I-N annual members’ survey.

Implementation Workshop - an Implementation Workshop will be held prior to the 2011 G-I-N conference.

Implementation Research Network - Anna Gagliardi is leading a project to establish a research network to investigate guideline implementability.

Call for expressions of interest

For people who have the time, commitment and interest to be more active and involved in the group’s work - we are keen to hear from you! You would need to be prepared to attend a teleconference 4-6 times a year. The need to link people in several countries means that (depending on where you live) these can be at unsociable times (early in the morning or late at night). In addition each member of the steering group contributes to building the implementation capability and resource within G-I-N by spending some hours actively working on issues identified as IWG priorities. You would also need to be a member of G-I-N (either through your employing organization or as an individual).

If you are interested please email details (including areas where you have specific interests, expertise and time to contribute) to Martina Westermann at:


We will continue to hold a meeting during the G-I-N annual conference for people who are interested in implementation but who do not have the time to contribute to IWG projects.

Evidence Tables working group

Since its last update in enGINe, the Evidence Tables Working Group has made considerable progress.

In April a number of volunteers participated in the evaluation study of a prognostic template. The results of this evaluation showed that there were a number of problems with the template, mainly on the following items:

  • Type of Prognostic Study,
  • Study Design,
  • Numbers,
  • Effect Size of Prognostic Factors and Prognostic Factors, and
  • Potential Confounders

On this basis work is being done to refine the template. The improved version will be discussed during the workshop of the ETWG at the G-I-N conference this August in Seoul.

The template to summarise economic evaluations is currently being pilot tested.

Meanwhile, work has progressed in developing GINDER, the G-I-N Data Extraction Resource, and we plan on launching this new G-I-N tool at the conference. To begin with, GINDER will enable summarising studies addressing diagnostic accuracy according to the previously developed template. The tool will then be further developed to enable summarising studies addressing intervention questions and then prognostic studies and economic evaluation studies once these templates are finalised.

We are looking forward to seeing you at the workshop and launch in Seoul this August.

For more information on the Evidence Tables Working Group and the templates visit the group’s web pages:

To learn more on GINDER please view the presentation:

Page last updated: Jul 02, 2011
Back to top